Postmenopausal Osteoporosis

Postmenopausal Osteoporosis is the indication for 14 drugs in DrugBank. It is covered by 17 curated, structured indications.

Also known as: Osteoporosis, Postmenopausal · Postmenopausal Bone Loss · Perimenopausal Bone Loss · Postmenopausal Women With Osteoporosis · Osteoporosis in Post-menopausal Women
Classified under: Age related issues
Musculoskeletal and Connective Tissue Diseases
Nutritional and Metabolic Diseases
Reproductive Physiological Processes
Indicated drugs: Bazedoxifene
Calcium carbonate
Calcium gluconate
Cholecalciferol
Cyproterone acetate
Estradiol
Estradiol valerate
Estrone sulfate
Levonorgestrel
Medroxyprogesterone acetate
Nandrolone decanoate
Norethisterone
Norgestimate
Raloxifene

Resolves to

Vocabularies

MeSHM0024020ICD-10M81.0SNOMED CT102447009MedDRA10031285UMLSC0029458

What you can answer from here — as of October 22, 2026

14Indicated drugsWith each drug's targets and mechanism

Listed above

17Structured indicationsPopulation, line of therapy, route and combination as fields, not prose

254Clinical trialsPhase, status and sponsor resolved per trial

1Drug reporting it as an adverse effectWith incidence where the label states it

Which approved drugs for Postmenopausal Osteoporosis share a target, and which companies have late-stage candidates against it?

Create a free account or log in to explore the full data card.